Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Assura plc ( (GB:AGR) ) is now available.
Assura plc announced that Ed Smith, the Chairman, sold his entire holding of 166,649 ordinary shares, while Jenny Smith, a connected person, sold 50,486 shares. These transactions, conducted on 13 August 2025, were disclosed in compliance with the Market Abuse Regulation. The sale of shares by the Chairman and a connected person might impact investor perceptions and could influence the company’s stock performance, given the significant stake involved.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Spark’s Take on GB:AGR Stock
According to Spark, TipRanks’ AI Analyst, GB:AGR is a Outperform.
Assura plc’s strong valuation and positive corporate events are the most significant factors driving the score. Financial performance is robust, though rising debt levels and declining free cash flow growth need monitoring. Technical indicators suggest a neutral market sentiment.
To see Spark’s full report on GB:AGR stock, click here.
More about Assura plc
Assura plc is the UK’s leading diversified healthcare Real Estate Investment Trust (REIT), managing a portfolio of over 600 healthcare buildings serving more than six million patients. Based in Altrincham, Assura is part of the FTSE 250 and EPRA indices, with a secondary listing on the Johannesburg Stock Exchange. As the first FTSE 250 certified B Corp, Assura is committed to integrating ESG principles into its operations, focusing on creating Healthy Environments, Healthy Communities, and maintaining a Healthy Business.
Average Trading Volume: 23,716,506
Technical Sentiment Signal: Buy
Current Market Cap: £1.61B
See more data about AGR stock on TipRanks’ Stock Analysis page.